drugset / Trial / NCT03771326

KP-10 and Insulin Secretion in Men

NCT03771326 ↗

Phase 3 Completed 14 enrolled Quaid-e-Azam University
RandomizedParallel-groupOpen-labelBasic science

Summary

Induction of insulin secretion by kisspeptin is observed in mouse, pig, rat, and human islets in vitro and in rats, mice and monkeys in vivo, but its mechanism is not fully clear. The present study was designed to investigate the role of KP-10 on insulin secretion in adult healthy and obese men with insulin resistance. The aim of selection of obese persons for the present study was to investigate the effect of acute KP-10 administration in a metabolically challenged condition where the pancreatic beta cells are already highly activated. The long-term objective of this study was to understand the physiological role of kisspeptin signalling in the regulation of insulin secretion in human health and disease.

Timeline

Start
2013-10-29
Primary completion
2013-11-04
Completion
2014-01-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Kisspeptin-10 Peptide 0.5 ug/kg Intravenous

Indications

No indication recorded.